Pulmonary Embolism Therapeutics Market Size & Competitors

The pulmonary embolism therapeutics market is forecasted to grow by USD 16.69 billion during 2024-2029, accelerating at a CAGR of 11.7% during the forecast period. The report on the pulmonary embolism therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing risk of adverse health conditions, increase in geriatric population, and rise in research and development activities for pulmonary embolism therapeutics.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

The pulmonary embolism therapeutics market is segmented as below:

By Application

Hospitals
Ambulatory surgical centers
Research institutes

By Route Of Administration

Oral
Parenteral

By Drug Class

Direct oral anticoagulants (DOACs)
Heparins vitamin K
Antagonists

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the advancements in healthcare and medical sector as one of the prime reasons driving the pulmonary embolism therapeutics market growth during the next few years. Also, increasing awareness regarding pulmonary embolism and growing number of partnerships and collaborations on therapeutics will lead to sizable demand in the market.

The report on the pulmonary embolism therapeutics market covers the following areas:

Pulmonary Embolism Therapeutics Market sizing
Pulmonary Embolism Therapeutics Market forecast
Pulmonary Embolism Therapeutics Market industry analysis

A robust vendor analysis within the report is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading pulmonary embolism therapeutics market vendors that include AbbVie Inc., Astellas Pharma Inc., Bayer AG, Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co., Daiichi Sankyo Co. Ltd., F. Hoffmann La Roche Ltd., Inari Medical Inc., Johnson and Johnson Services Inc., Medtronic Plc, Novartis AG, Pfizer Inc., Sanofi SA, Takeda Pharmaceutical Co. Ltd., and Viatris Inc. Also, the pulmonary embolism therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary

1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Application
Executive Summary - Chart on Market Segmentation by Route of Administration
Executive Summary - Chart on Market Segmentation by Drug Class
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning

2 Market Analysis

2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
Overview on factors of disruption
2.4 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

3.1 Market ecosystem
Parent Market
Data Table on - Parent Market
3.2 Market characteristics
Market characteristics analysis
3.3 Value chain analysis
Value chain analysis

4 Market Sizing

4.1 Market definition
Offerings of companies included in the market definition
4.2 Market segment analysis
Market segments
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
Chart on Global - Market size and forecast 2024-2029 ($ million)
Data Table on Global - Market size and forecast 2024-2029 ($ million)
Chart on Global Market: Year-over-year growth 2024-2029 (%)
Data Table on Global Market: Year-over-year growth 2024-2029 (%)

5 Historic Market Size

5.1 Global Pulmonary Embolism Therapeutics Market 2019 - 2023
Historic Market Size - Data Table on Global Pulmonary Embolism Therapeutics Market 2019 - 2023 ($ million)
5.2 Application segment analysis 2019 - 2023
Historic Market Size - Application Segment 2019 - 2023 ($ million)
5.3 Route of Administration segment analysis 2019 - 2023
Historic Market Size - Route of Administration Segment 2019 - 2023 ($ million)
5.4 Drug Class segment analysis 2019 - 2023
Historic Market Size - Drug Class Segment 2019 - 2023 ($ million)
5.5 Geography segment analysis 2019 - 2023
Historic Market Size - Geography Segment 2019 - 2023 ($ million)
5.6 Country segment analysis 2019 - 2023
Historic Market Size - Country Segment 2019 - 2023 ($ million)

6 Qualitative Analysis

6.1 The AI impact on global pulmonary embolism therapeutics market

7 Five Forces Analysis

7.1 Five forces summary
Five forces analysis - Comparison between 2024 and 2029
7.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2024 and 2029
7.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2024 and 2029
7.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2024 and 2029
7.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2024 and 2029
7.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2024 and 2029
7.7 Market condition
Chart on Market condition - Five forces 2024 and 2029

8 Market Segmentation by Application

8.1 Market segments
Chart on Application - Market share 2024-2029 (%)
Data Table on Application - Market share 2024-2029 (%)
8.2 Comparison by Application
Chart on Comparison by Application
Data Table on Comparison by Application
8.3 Hospitals - Market size and forecast 2024-2029
Chart on Hospitals - Market size and forecast 2024-2029 ($ million)
Data Table on Hospitals - Market size and forecast 2024-2029 ($ million)
Chart on Hospitals - Year-over-year growth 2024-2029 (%)
Data Table on Hospitals - Year-over-year growth 2024-2029 (%)
8.4 Ambulatory surgical centers - Market size and forecast 2024-2029
Chart on Ambulatory surgical centers - Market size and forecast 2024-2029 ($ million)
Data Table on Ambulatory surgical centers - Market size and forecast 2024-2029 ($ million)
Chart on Ambulatory surgical centers - Year-over-year growth 2024-2029 (%)
Data Table on Ambulatory surgical centers - Year-over-year growth 2024-2029 (%)
8.5 Research institutes - Market size and forecast 2024-2029
Chart on Research institutes - Market size and forecast 2024-2029 ($ million)
Data Table on Research institutes - Market size and forecast 2024-2029 ($ million)
Chart on Research institutes - Year-over-year growth 2024-2029 (%)
Data Table on Research institutes - Year-over-year growth 2024-2029 (%)
8.6 Market opportunity by Application
Market opportunity by Application ($ million)
Data Table on Market opportunity by Application ($ million)

9 Market Segmentation by Route of Administration

9.1 Market segments
Chart on Route of Administration - Market share 2024-2029 (%)
Data Table on Route of Administration - Market share 2024-2029 (%)
9.2 Comparison by Route of Administration
Chart on Comparison by Route of Administration
Data Table on Comparison by Route of Administration
9.3 Oral - Market size and forecast 2024-2029
Chart on Oral - Market size and forecast 2024-2029 ($ million)
Data Table on Oral - Market size and forecast 2024-2029 ($ million)
Chart on Oral - Year-over-year growth 2024-2029 (%)
Data Table on Oral - Year-over-year growth 2024-2029 (%)
9.4 Parenteral - Market size and forecast 2024-2029
Chart on Parenteral - Market size and forecast 2024-2029 ($ million)
Data Table on Parenteral - Market size and forecast 2024-2029 ($ million)
Chart on Parenteral - Year-over-year growth 2024-2029 (%)
Data Table on Parenteral - Year-over-year growth 2024-2029 (%)
9.5 Market opportunity by Route of Administration
Market opportunity by Route of Administration ($ million)
Data Table on Market opportunity by Route of Administration ($ million)

10 Market Segmentation by Drug Class

10.1 Market segments
Chart on Drug Class - Market share 2024-2029 (%)
Data Table on Drug Class - Market share 2024-2029 (%)
10.2 Comparison by Drug Class
Chart on Comparison by Drug Class
Data Table on Comparison by Drug Class
10.3 Direct oral anticoagulants (DOACs) - Market size and forecast 2024-2029
Chart on Direct oral anticoagulants (DOACs) - Market size and forecast 2024-2029 ($ million)
Data Table on Direct oral anticoagulants (DOACs) - Market size and forecast 2024-2029 ($ million)
Chart on Direct oral anticoagulants (DOACs) - Year-over-year growth 2024-2029 (%)
Data Table on Direct oral anticoagulants (DOACs) - Year-over-year growth 2024-2029 (%)
10.4 Heparins vitamin K - Market size and forecast 2024-2029
Chart on Heparins vitamin K - Market size and forecast 2024-2029 ($ million)
Data Table on Heparins vitamin K - Market size and forecast 2024-2029 ($ million)
Chart on Heparins vitamin K - Year-over-year growth 2024-2029 (%)
Data Table on Heparins vitamin K - Year-over-year growth 2024-2029 (%)
10.5 Antagonists - Market size and forecast 2024-2029
Chart on Antagonists - Market size and forecast 2024-2029 ($ million)
Data Table on Antagonists - Market size and forecast 2024-2029 ($ million)
Chart on Antagonists - Year-over-year growth 2024-2029 (%)
Data Table on Antagonists - Year-over-year growth 2024-2029 (%)
10.6 Market opportunity by Drug Class
Market opportunity by Drug Class ($ million)
Data Table on Market opportunity by Drug Class ($ million)

11 Customer Landscape

11.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

12.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2024-2029 (%)
Data Table on Market share By Geographical Landscape 2024-2029 (%)
12.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
12.3 North America - Market size and forecast 2024-2029
Chart on North America - Market size and forecast 2024-2029 ($ million)
Data Table on North America - Market size and forecast 2024-2029 ($ million)
Chart on North America - Year-over-year growth 2024-2029 (%)
Data Table on North America - Year-over-year growth 2024-2029 (%)
12.4 Europe - Market size and forecast 2024-2029
Chart on Europe - Market size and forecast 2024-2029 ($ million)
Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Chart on Europe - Year-over-year growth 2024-2029 (%)
Data Table on Europe - Year-over-year growth 2024-2029 (%)
12.5 Asia - Market size and forecast 2024-2029
Chart on Asia - Market size and forecast 2024-2029 ($ million)
Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Chart on Asia - Year-over-year growth 2024-2029 (%)
Data Table on Asia - Year-over-year growth 2024-2029 (%)
12.6 Rest of World (ROW) - Market size and forecast 2024-2029
Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
12.7 US - Market size and forecast 2024-2029
Chart on US - Market size and forecast 2024-2029 ($ million)
Data Table on US - Market size and forecast 2024-2029 ($ million)
Chart on US - Year-over-year growth 2024-2029 (%)
Data Table on US - Year-over-year growth 2024-2029 (%)
12.8 Canada - Market size and forecast 2024-2029
Chart on Canada - Market size and forecast 2024-2029 ($ million)
Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Chart on Canada - Year-over-year growth 2024-2029 (%)
Data Table on Canada - Year-over-year growth 2024-2029 (%)
12.9 France - Market size and forecast 2024-2029
Chart on France - Market size and forecast 2024-2029 ($ million)
Data Table on France - Market size and forecast 2024-2029 ($ million)
Chart on France - Year-over-year growth 2024-2029 (%)
Data Table on France - Year-over-year growth 2024-2029 (%)
12.10 Japan - Market size and forecast 2024-2029
Chart on Japan - Market size and forecast 2024-2029 ($ million)
Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Chart on Japan - Year-over-year growth 2024-2029 (%)
Data Table on Japan - Year-over-year growth 2024-2029 (%)
12.11 Norway - Market size and forecast 2024-2029
Chart on Norway - Market size and forecast 2024-2029 ($ million)
Data Table on Norway - Market size and forecast 2024-2029 ($ million)
Chart on Norway - Year-over-year growth 2024-2029 (%)
Data Table on Norway - Year-over-year growth 2024-2029 (%)
12.12 Brazil - Market size and forecast 2024-2029
Chart on Brazil - Market size and forecast 2024-2029 ($ million)
Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
Chart on Brazil - Year-over-year growth 2024-2029 (%)
Data Table on Brazil - Year-over-year growth 2024-2029 (%)
12.13 UK - Market size and forecast 2024-2029
Chart on UK - Market size and forecast 2024-2029 ($ million)
Data Table on UK - Market size and forecast 2024-2029 ($ million)
Chart on UK - Year-over-year growth 2024-2029 (%)
Data Table on UK - Year-over-year growth 2024-2029 (%)
12.14 China - Market size and forecast 2024-2029
Chart on China - Market size and forecast 2024-2029 ($ million)
Data Table on China - Market size and forecast 2024-2029 ($ million)
Chart on China - Year-over-year growth 2024-2029 (%)
Data Table on China - Year-over-year growth 2024-2029 (%)
12.15 Germany - Market size and forecast 2024-2029
Chart on Germany - Market size and forecast 2024-2029 ($ million)
Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Chart on Germany - Year-over-year growth 2024-2029 (%)
Data Table on Germany - Year-over-year growth 2024-2029 (%)
12.16 Italy - Market size and forecast 2024-2029
Chart on Italy - Market size and forecast 2024-2029 ($ million)
Data Table on Italy - Market size and forecast 2024-2029 ($ million)
Chart on Italy - Year-over-year growth 2024-2029 (%)
Data Table on Italy - Year-over-year growth 2024-2029 (%)
12.17 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ million)
Data Tables on Market opportunity By Geographical Landscape ($ million)

13 Drivers, Challenges, and Opportunity/Restraints

13.1 Market drivers
13.2 Market challenges
13.3 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
13.4 Market opportunities/restraints

14 Competitive Landscape

14.1 Overview
14.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
14.3 Landscape disruption
Overview on factors of disruption
14.4 Industry risks
Impact of key risks on business

15 Competitive Analysis

15.1 Companies profiled
Companies covered
15.2 Company ranking index
Company ranking index
15.3 Market positioning of companies
Matrix on companies position and classification
15.4 AbbVie Inc.
AbbVie Inc. - Overview
AbbVie Inc. - Product / Service
AbbVie Inc. - Key news
AbbVie Inc. - Key offerings
SWOT
15.5 Astellas Pharma Inc.
Astellas Pharma Inc. - Overview
Astellas Pharma Inc. - Product / Service
Astellas Pharma Inc. - Key offerings
SWOT
15.6 Bayer AG
Bayer AG - Overview
Bayer AG - Business segments
Bayer AG - Key news
Bayer AG - Key offerings
Bayer AG - Segment focus
SWOT
15.7 Boehringer Ingelheim International GmbH
Boehringer Ingelheim International GmbH - Overview
Boehringer Ingelheim International GmbH - Product / Service
Boehringer Ingelheim International GmbH - Key news
Boehringer Ingelheim International GmbH - Key offerings
SWOT
15.8 Bristol Myers Squibb Co.
Bristol Myers Squibb Co. - Overview
Bristol Myers Squibb Co. - Product / Service
Bristol Myers Squibb Co. - Key news
Bristol Myers Squibb Co. - Key offerings
SWOT
15.9 Daiichi Sankyo Co. Ltd.
Daiichi Sankyo Co. Ltd. - Overview
Daiichi Sankyo Co. Ltd. - Product / Service
Daiichi Sankyo Co. Ltd. - Key offerings
SWOT
15.10 F. Hoffmann La Roche Ltd.
F. Hoffmann La Roche Ltd. - Overview
F. Hoffmann La Roche Ltd. - Business segments
F. Hoffmann La Roche Ltd. - Key news
F. Hoffmann La Roche Ltd. - Key offerings
F. Hoffmann La Roche Ltd. - Segment focus
SWOT
15.11 Inari Medical Inc.
Inari Medical Inc. - Overview
Inari Medical Inc. - Product / Service
Inari Medical Inc. - Key offerings
SWOT
15.12 Johnson and Johnson Services Inc.
Johnson and Johnson Services Inc. - Overview
Johnson and Johnson Services Inc. - Business segments
Johnson and Johnson Services Inc. - Key news
Johnson and Johnson Services Inc. - Key offerings
Johnson and Johnson Services Inc. - Segment focus
SWOT
15.13 Medtronic Plc
Medtronic Plc - Overview
Medtronic Plc - Business segments
Medtronic Plc - Key news
Medtronic Plc - Key offerings
Medtronic Plc - Segment focus
SWOT
15.14 Novartis AG
Novartis AG - Overview
Novartis AG - Business segments
Novartis AG - Key news
Novartis AG - Key offerings
Novartis AG - Segment focus
SWOT
15.15 Pfizer Inc.
Pfizer Inc. - Overview
Pfizer Inc. - Product / Service
Pfizer Inc. - Key news
Pfizer Inc. - Key offerings
SWOT
15.16 Sanofi SA
Sanofi SA - Overview
Sanofi SA - Business segments
Sanofi SA - Key news
Sanofi SA - Key offerings
Sanofi SA - Segment focus
SWOT
15.17 Takeda Pharmaceutical Co. Ltd.
Takeda Pharmaceutical Co. Ltd. - Overview
Takeda Pharmaceutical Co. Ltd. - Product / Service
Takeda Pharmaceutical Co. Ltd. - Key news
Takeda Pharmaceutical Co. Ltd. - Key offerings
SWOT
15.18 Viatris Inc.
Viatris Inc. - Overview
Viatris Inc. - Business segments
Viatris Inc. - Key news
Viatris Inc. - Key offerings
Viatris Inc. - Segment focus
SWOT

16 Appendix

16.1 Scope of the report
16.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
16.3 Currency conversion rates for US$
Currency conversion rates for US$
16.4 Research methodology
Research methodology
16.5 Data procurement
Information sources
16.6 Data validation
Data validation
16.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
16.8 Data synthesis
Data synthesis
16.9 360 degree market analysis
360 degree market analysis
16.10 List of abbreviations
List of abbreviations

List of Exhibits

Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Application
Exhibits 6: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits 7: Executive Summary - Chart on Market Segmentation by Drug Class
Exhibits 8: Executive Summary - Chart on Incremental Growth
Exhibits 9: Executive Summary - Data Table on Incremental Growth
Exhibits 10: Executive Summary - Chart on Company Market Positioning
Exhibits 11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 12: Overview on criticality of inputs and factors of differentiation
Exhibits 13: Overview on factors of disruption
Exhibits 14: Impact of drivers and challenges in 2024 and 2029
Exhibits 15: Parent Market
Exhibits 16: Data Table on - Parent Market
Exhibits 17: Market characteristics analysis
Exhibits 18: Value chain analysis
Exhibits 19: Offerings of companies included in the market definition
Exhibits 20: Market segments
Exhibits 21: Chart on Global - Market size and forecast 2024-2029 ($ million)
Exhibits 22: Data Table on Global - Market size and forecast 2024-2029 ($ million)
Exhibits 23: Chart on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits 24: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits 25: Historic Market Size - Data Table on Global Pulmonary Embolism Therapeutics Market 2019 - 2023 ($ million)
Exhibits 26: Historic Market Size - Application Segment 2019 - 2023 ($ million)
Exhibits 27: Historic Market Size - Route of Administration Segment 2019 - 2023 ($ million)
Exhibits 28: Historic Market Size - Drug Class Segment 2019 - 2023 ($ million)
Exhibits 29: Historic Market Size - Geography Segment 2019 - 2023 ($ million)
Exhibits 30: Historic Market Size - Country Segment 2019 - 2023 ($ million)
Exhibits 31: Five forces analysis - Comparison between 2024 and 2029
Exhibits 32: Bargaining power of buyers - Impact of key factors 2024 and 2029
Exhibits 33: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
Exhibits 34: Threat of new entrants - Impact of key factors in 2024 and 2029
Exhibits 35: Threat of substitutes - Impact of key factors in 2024 and 2029
Exhibits 36: Threat of rivalry - Impact of key factors in 2024 and 2029
Exhibits 37: Chart on Market condition - Five forces 2024 and 2029
Exhibits 38: Chart on Application - Market share 2024-2029 (%)
Exhibits 39: Data Table on Application - Market share 2024-2029 (%)
Exhibits 40: Chart on Comparison by Application
Exhibits 41: Data Table on Comparison by Application
Exhibits 42: Chart on Hospitals - Market size and forecast 2024-2029 ($ million)
Exhibits 43: Data Table on Hospitals - Market size and forecast 2024-2029 ($ million)
Exhibits 44: Chart on Hospitals - Year-over-year growth 2024-2029 (%)
Exhibits 45: Data Table on Hospitals - Year-over-year growth 2024-2029 (%)
Exhibits 46: Chart on Ambulatory surgical centers - Market size and forecast 2024-2029 ($ million)
Exhibits 47: Data Table on Ambulatory surgical centers - Market size and forecast 2024-2029 ($ million)
Exhibits 48: Chart on Ambulatory surgical centers - Year-over-year growth 2024-2029 (%)
Exhibits 49: Data Table on Ambulatory surgical centers - Year-over-year growth 2024-2029 (%)
Exhibits 50: Chart on Research institutes - Market size and forecast 2024-2029 ($ million)
Exhibits 51: Data Table on Research institutes - Market size and forecast 2024-2029 ($ million)
Exhibits 52: Chart on Research institutes - Year-over-year growth 2024-2029 (%)
Exhibits 53: Data Table on Research institutes - Year-over-year growth 2024-2029 (%)
Exhibits 54: Market opportunity by Application ($ million)
Exhibits 55: Data Table on Market opportunity by Application ($ million)
Exhibits 56: Chart on Route of Administration - Market share 2024-2029 (%)
Exhibits 57: Data Table on Route of Administration - Market share 2024-2029 (%)
Exhibits 58: Chart on Comparison by Route of Administration
Exhibits 59: Data Table on Comparison by Route of Administration
Exhibits 60: Chart on Oral - Market size and forecast 2024-2029 ($ million)
Exhibits 61: Data Table on Oral - Market size and forecast 2024-2029 ($ million)
Exhibits 62: Chart on Oral - Year-over-year growth 2024-2029 (%)
Exhibits 63: Data Table on Oral - Year-over-year growth 2024-2029 (%)
Exhibits 64: Chart on Parenteral - Market size and forecast 2024-2029 ($ million)
Exhibits 65: Data Table on Parenteral - Market size and forecast 2024-2029 ($ million)
Exhibits 66: Chart on Parenteral - Year-over-year growth 2024-2029 (%)
Exhibits 67: Data Table on Parenteral - Year-over-year growth 2024-2029 (%)
Exhibits 68: Market opportunity by Route of Administration ($ million)
Exhibits 69: Data Table on Market opportunity by Route of Administration ($ million)
Exhibits 70: Chart on Drug Class - Market share 2024-2029 (%)
Exhibits 71: Data Table on Drug Class - Market share 2024-2029 (%)
Exhibits 72: Chart on Comparison by Drug Class
Exhibits 73: Data Table on Comparison by Drug Class
Exhibits 74: Chart on Direct oral anticoagulants (DOACs) - Market size and forecast 2024-2029 ($ million)
Exhibits 75: Data Table on Direct oral anticoagulants (DOACs) - Market size and forecast 2024-2029 ($ million)
Exhibits 76: Chart on Direct oral anticoagulants (DOACs) - Year-over-year growth 2024-2029 (%)
Exhibits 77: Data Table on Direct oral anticoagulants (DOACs) - Year-over-year growth 2024-2029 (%)
Exhibits 78: Chart on Heparins vitamin K - Market size and forecast 2024-2029 ($ million)
Exhibits 79: Data Table on Heparins vitamin K - Market size and forecast 2024-2029 ($ million)
Exhibits 80: Chart on Heparins vitamin K - Year-over-year growth 2024-2029 (%)
Exhibits 81: Data Table on Heparins vitamin K - Year-over-year growth 2024-2029 (%)
Exhibits 82: Chart on Antagonists - Market size and forecast 2024-2029 ($ million)
Exhibits 83: Data Table on Antagonists - Market size and forecast 2024-2029 ($ million)
Exhibits 84: Chart on Antagonists - Year-over-year growth 2024-2029 (%)
Exhibits 85: Data Table on Antagonists - Year-over-year growth 2024-2029 (%)
Exhibits 86: Market opportunity by Drug Class ($ million)
Exhibits 87: Data Table on Market opportunity by Drug Class ($ million)
Exhibits 88: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 89: Chart on Market share By Geographical Landscape 2024-2029 (%)
Exhibits 90: Data Table on Market share By Geographical Landscape 2024-2029 (%)
Exhibits 91: Chart on Geographic comparison
Exhibits 92: Data Table on Geographic comparison
Exhibits 93: Chart on North America - Market size and forecast 2024-2029 ($ million)
Exhibits 94: Data Table on North America - Market size and forecast 2024-2029 ($ million)
Exhibits 95: Chart on North America - Year-over-year growth 2024-2029 (%)
Exhibits 96: Data Table on North America - Year-over-year growth 2024-2029 (%)
Exhibits 97: Chart on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits 98: Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits 99: Chart on Europe - Year-over-year growth 2024-2029 (%)
Exhibits 100: Data Table on Europe - Year-over-year growth 2024-2029 (%)
Exhibits 101: Chart on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits 102: Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits 103: Chart on Asia - Year-over-year growth 2024-2029 (%)
Exhibits 104: Data Table on Asia - Year-over-year growth 2024-2029 (%)
Exhibits 105: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits 106: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits 107: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits 108: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits 109: Chart on US - Market size and forecast 2024-2029 ($ million)
Exhibits 110: Data Table on US - Market size and forecast 2024-2029 ($ million)
Exhibits 111: Chart on US - Year-over-year growth 2024-2029 (%)
Exhibits 112: Data Table on US - Year-over-year growth 2024-2029 (%)
Exhibits 113: Chart on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits 114: Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits 115: Chart on Canada - Year-over-year growth 2024-2029 (%)
Exhibits 116: Data Table on Canada - Year-over-year growth 2024-2029 (%)
Exhibits 117: Chart on France - Market size and forecast 2024-2029 ($ million)
Exhibits 118: Data Table on France - Market size and forecast 2024-2029 ($ million)
Exhibits 119: Chart on France - Year-over-year growth 2024-2029 (%)
Exhibits 120: Data Table on France - Year-over-year growth 2024-2029 (%)
Exhibits 121: Chart on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits 122: Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits 123: Chart on Japan - Year-over-year growth 2024-2029 (%)
Exhibits 124: Data Table on Japan - Year-over-year growth 2024-2029 (%)
Exhibits 125: Chart on Norway - Market size and forecast 2024-2029 ($ million)
Exhibits 126: Data Table on Norway - Market size and forecast 2024-2029 ($ million)
Exhibits 127: Chart on Norway - Year-over-year growth 2024-2029 (%)
Exhibits 128: Data Table on Norway - Year-over-year growth 2024-2029 (%)
Exhibits 129: Chart on Brazil - Market size and forecast 2024-2029 ($ million)
Exhibits 130: Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
Exhibits 131: Chart on Brazil - Year-over-year growth 2024-2029 (%)
Exhibits 132: Data Table on Brazil - Year-over-year growth 2024-2029 (%)
Exhibits 133: Chart on UK - Market size and forecast 2024-2029 ($ million)
Exhibits 134: Data Table on UK - Market size and forecast 2024-2029 ($ million)
Exhibits 135: Chart on UK - Year-over-year growth 2024-2029 (%)
Exhibits 136: Data Table on UK - Year-over-year growth 2024-2029 (%)
Exhibits 137: Chart on China - Market size and forecast 2024-2029 ($ million)
Exhibits 138: Data Table on China - Market size and forecast 2024-2029 ($ million)
Exhibits 139: Chart on China - Year-over-year growth 2024-2029 (%)
Exhibits 140: Data Table on China - Year-over-year growth 2024-2029 (%)
Exhibits 141: Chart on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits 142: Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits 143: Chart on Germany - Year-over-year growth 2024-2029 (%)
Exhibits 144: Data Table on Germany - Year-over-year growth 2024-2029 (%)
Exhibits 145: Chart on Italy - Market size and forecast 2024-2029 ($ million)
Exhibits 146: Data Table on Italy - Market size and forecast 2024-2029 ($ million)
Exhibits 147: Chart on Italy - Year-over-year growth 2024-2029 (%)
Exhibits 148: Data Table on Italy - Year-over-year growth 2024-2029 (%)
Exhibits 149: Market opportunity By Geographical Landscape ($ million)
Exhibits 150: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 151: Impact of drivers and challenges in 2024 and 2029
Exhibits 152: Overview on criticality of inputs and factors of differentiation
Exhibits 153: Overview on factors of disruption
Exhibits 154: Impact of key risks on business
Exhibits 155: Companies covered
Exhibits 156: Company ranking index
Exhibits 157: Matrix on companies position and classification
Exhibits 158: AbbVie Inc. - Overview
Exhibits 159: AbbVie Inc. - Product / Service
Exhibits 160: AbbVie Inc. - Key news
Exhibits 161: AbbVie Inc. - Key offerings
Exhibits 162: SWOT
Exhibits 163: Astellas Pharma Inc. - Overview
Exhibits 164: Astellas Pharma Inc. - Product / Service
Exhibits 165: Astellas Pharma Inc. - Key offerings
Exhibits 166: SWOT
Exhibits 167: Bayer AG - Overview
Exhibits 168: Bayer AG - Business segments
Exhibits 169: Bayer AG - Key news
Exhibits 170: Bayer AG - Key offerings
Exhibits 171: Bayer AG - Segment focus
Exhibits 172: SWOT
Exhibits 173: Boehringer Ingelheim International GmbH - Overview
Exhibits 174: Boehringer Ingelheim International GmbH - Product / Service
Exhibits 175: Boehringer Ingelheim International GmbH - Key news
Exhibits 176: Boehringer Ingelheim International GmbH - Key offerings
Exhibits 177: SWOT
Exhibits 178: Bristol Myers Squibb Co. - Overview
Exhibits 179: Bristol Myers Squibb Co. - Product / Service
Exhibits 180: Bristol Myers Squibb Co. - Key news
Exhibits 181: Bristol Myers Squibb Co. - Key offerings
Exhibits 182: SWOT
Exhibits 183: Daiichi Sankyo Co. Ltd. - Overview
Exhibits 184: Daiichi Sankyo Co. Ltd. - Product / Service
Exhibits 185: Daiichi Sankyo Co. Ltd. - Key offerings
Exhibits 186: SWOT
Exhibits 187: F. Hoffmann La Roche Ltd. - Overview
Exhibits 188: F. Hoffmann La Roche Ltd. - Business segments
Exhibits 189: F. Hoffmann La Roche Ltd. - Key news
Exhibits 190: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits 191: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits 192: SWOT
Exhibits 193: Inari Medical Inc. - Overview
Exhibits 194: Inari Medical Inc. - Product / Service
Exhibits 195: Inari Medical Inc. - Key offerings
Exhibits 196: SWOT
Exhibits 197: Johnson and Johnson Services Inc. - Overview
Exhibits 198: Johnson and Johnson Services Inc. - Business segments
Exhibits 199: Johnson and Johnson Services Inc. - Key news
Exhibits 200: Johnson and Johnson Services Inc. - Key offerings
Exhibits 201: Johnson and Johnson Services Inc. - Segment focus
Exhibits 202: SWOT
Exhibits 203: Medtronic Plc - Overview
Exhibits 204: Medtronic Plc - Business segments
Exhibits 205: Medtronic Plc - Key news
Exhibits 206: Medtronic Plc - Key offerings
Exhibits 207: Medtronic Plc - Segment focus
Exhibits 208: SWOT
Exhibits 209: Novartis AG - Overview
Exhibits 210: Novartis AG - Business segments
Exhibits 211: Novartis AG - Key news
Exhibits 212: Novartis AG - Key offerings
Exhibits 213: Novartis AG - Segment focus
Exhibits 214: SWOT
Exhibits 215: Pfizer Inc. - Overview
Exhibits 216: Pfizer Inc. - Product / Service
Exhibits 217: Pfizer Inc. - Key news
Exhibits 218: Pfizer Inc. - Key offerings
Exhibits 219: SWOT
Exhibits 220: Sanofi SA - Overview
Exhibits 221: Sanofi SA - Business segments
Exhibits 222: Sanofi SA - Key news
Exhibits 223: Sanofi SA - Key offerings
Exhibits 224: Sanofi SA - Segment focus
Exhibits 225: SWOT
Exhibits 226: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits 227: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits 228: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits 229: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits 230: SWOT
Exhibits 231: Viatris Inc. - Overview
Exhibits 232: Viatris Inc. - Business segments
Exhibits 233: Viatris Inc. - Key news
Exhibits 234: Viatris Inc. - Key offerings
Exhibits 235: Viatris Inc. - Segment focus
Exhibits 236: SWOT
Exhibits 237: Inclusions checklist
Exhibits 238: Exclusions checklist
Exhibits 239: Currency conversion rates for US$
Exhibits 240: Research methodology
Exhibits 241: Information sources
Exhibits 242: Data validation
Exhibits 243: Validation techniques employed for market sizing
Exhibits 244: Data synthesis
Exhibits 245: 360 degree market analysis
Exhibits 246: List of abbreviations

Executive Summary

The following companies are recognized as the key players in the global pulmonary embolism therapeutics market: AbbVie Inc., Astellas Pharma Inc., Bayer AG, Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co., Daiichi Sankyo Co. Ltd., F. Hoffmann La Roche Ltd., Inari Medical Inc., Johnson and Johnson Services Inc., Medtronic Plc, Novartis AG, Pfizer Inc., Sanofi SA, Takeda Pharmaceutical Co. Ltd., and Viatris Inc..

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is advancements in healthcare and medical sector."

According to the report, one of the major drivers for this market is the growing risk of adverse health conditions.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

AbbVie Inc.
Astellas Pharma Inc.
Bayer AG
Boehringer Ingelheim International GmbH
Bristol Myers Squibb Co.
Daiichi Sankyo Co. Ltd.
F. Hoffmann La Roche Ltd.
Inari Medical Inc.
Johnson and Johnson Services Inc.
Medtronic Plc
Novartis AG
Pfizer Inc.
Sanofi SA
Takeda Pharmaceutical Co. Ltd.
Viatris Inc.

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€2195EUR$2,500USD£1,883GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€3511EUR$4,000USD£3,013GBP

Pulmonary Embolism Therapeutics Market 2025-2029

The pulmonary embolism therapeutics market is segmented as below:

By Application

By Route Of Administration

By Drug Class

By Geographical Landscape

The report on the pulmonary embolism therapeutics market covers the following areas:

Table of Contents

Executive Summary

Companies Mentioned (Partial List)

The pulmonary embolism therapeutics market is segmented as below:

By Application

By Route Of Administration

By Drug Class

By Geographical Landscape

The report on the pulmonary embolism therapeutics market covers the following areas:

Table of Contents

Executive Summary

Companies Mentioned (Partial List)

Related Topics

Related Reports

Pulmonary embolism Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

Thrombosis Drugs Market 2024-2028

Pulmonary Arterial Hypertension (PAH) Drugs Market 2024-2028

Anticoagulants Market - Forecasts from 2025 to 2030

Venous Thromboembolism Market Report 2025

About the Pulmonary Embolism Drug Market